Stock Earnings
Amylyx Pharmaceuticals Inc (AMLX) receives a Buy rating from Goldman
Amylyx Pharmaceuticals Inc’s recently made public that its Chief Financial Officer FRATES JAMES M unloaded Company’s shares for reported $37806.0
Menu
Amylyx Pharmaceuticals Inc’s recently made public that its Chief Financial Officer FRATES JAMES M unloaded Company’s shares for reported $37806.0
Amylyx Pharmaceuticals Inc’s recent filing unveils that its Chief Financial Officer FRATES JAMES M unloaded Company’s shares for reported $37806.0
Amylyx Pharmaceuticals Inc’s recent filing unveils that its Chief Financial Officer FRATES JAMES M unloaded Company’s shares for reported $37806.0
Amylyx Pharmaceuticals Inc’s filing revealed that its Chief Financial Officer FRATES JAMES M unloaded Company’s shares for reported $37806.0 on
In a filing, Amylyx Pharmaceuticals Inc revealed its Chief Financial Officer FRATES JAMES M unloaded Company’s shares for reported $37806.0
Amylyx Pharmaceuticals Inc’s filing revealed that its Chief Financial Officer FRATES JAMES M unloaded Company’s shares for reported $37806.0 on
In a filing, Amylyx Pharmaceuticals Inc revealed its Chief Financial Officer FRATES JAMES M unloaded Company’s shares for reported $37806.0